Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 107.11 billion as of October 6, 2025. Its market cap has decreased by -14.48% in one year.

Market Cap

107.11B

Enterprise Value

n/a

Revenue

108.14B

Ranking

n/a

PE Ratio

64.14

Stock Price

3,865.00

Market Cap Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 107.11B, an increase of 272.24%. That is a compound annual growth rate of 4.46%.

Market Cap History

Date	Market Cap	% Change
Oct 2, 2025	107.11B	7.95%
Dec 30, 2024	99.22B	-12.77%
Dec 28, 2023	113.76B	-14.20%
Dec 29, 2022	132.58B	-19.22%
Dec 30, 2021	164.12B	-22.93%
Dec 30, 2020	212.94B	47.61%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.81T
Celltrion	38.64T
ALTEOGEN	25.22T
Yuhan	8,969.60B
SK Biopharmaceuticals	8,144.58B
Peptron	7,006.86B
PharmaResearch	5,714.31B
LigaChem Biosciences	5,545.53B

Market Cap Rankings